share_log
Reuters ·  Dec 19 21:00
Xentria Announces Exclusive Licensing Agreement With New York University to Advance a Disease-Modifying Cardiovascular Therapy Globally
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment